ATE420870T1 - Verfahren zur herstellung von citalopram - Google Patents
Verfahren zur herstellung von citalopramInfo
- Publication number
- ATE420870T1 ATE420870T1 AT04791287T AT04791287T ATE420870T1 AT E420870 T1 ATE420870 T1 AT E420870T1 AT 04791287 T AT04791287 T AT 04791287T AT 04791287 T AT04791287 T AT 04791287T AT E420870 T1 ATE420870 T1 AT E420870T1
- Authority
- AT
- Austria
- Prior art keywords
- citalopram
- producing citalopram
- cyanophthalide
- cyclized
- bromine
- Prior art date
Links
- 229960001653 citalopram Drugs 0.000 title abstract 2
- WSEQXVZVJXJVFP-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Chemical compound O1CC2=CC(C#N)=CC=C2C1(CCCN(C)C)C1=CC=C(F)C=C1 WSEQXVZVJXJVFP-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 abstract 1
- XEEGWTLAFIZLSF-UHFFFAOYSA-N 1-oxo-3h-2-benzofuran-5-carbonitrile Chemical compound N#CC1=CC=C2C(=O)OCC2=C1 XEEGWTLAFIZLSF-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- BRKADVNLTRCLOW-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=[C-]C=C1 BRKADVNLTRCLOW-UHFFFAOYSA-M 0.000 abstract 1
- NGPAITITALWALP-UHFFFAOYSA-M magnesium;n,n-dimethylpropan-1-amine;chloride Chemical compound [Mg+2].[Cl-].CN(C)CC[CH2-] NGPAITITALWALP-UHFFFAOYSA-M 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03425693A EP1506963B1 (de) | 2003-10-28 | 2003-10-28 | Verfahren zur Herstellung von Citalopram |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE420870T1 true ATE420870T1 (de) | 2009-01-15 |
Family
ID=33560918
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03425693T ATE293106T1 (de) | 2003-10-28 | 2003-10-28 | Verfahren zur herstellung von citalopram |
AT04791287T ATE420870T1 (de) | 2003-10-28 | 2004-10-22 | Verfahren zur herstellung von citalopram |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03425693T ATE293106T1 (de) | 2003-10-28 | 2003-10-28 | Verfahren zur herstellung von citalopram |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070060759A1 (de) |
EP (2) | EP1506963B1 (de) |
JP (1) | JP2007511477A (de) |
CN (1) | CN1875013A (de) |
AT (2) | ATE293106T1 (de) |
BR (1) | BRPI0415778A (de) |
CA (1) | CA2543155A1 (de) |
DE (2) | DE60300502T2 (de) |
DK (2) | DK1506963T3 (de) |
ES (1) | ES2240931T3 (de) |
HK (1) | HK1075041A1 (de) |
PL (1) | PL379659A1 (de) |
PT (1) | PT1506963E (de) |
SI (1) | SI1506963T1 (de) |
WO (1) | WO2005049595A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9314444B2 (en) | 2009-01-12 | 2016-04-19 | Biokier, Inc. | Composition and method for treatment of NASH |
US9006288B2 (en) | 2009-01-12 | 2015-04-14 | Biokier, Inc. | Composition and method for treatment of diabetes |
US8470885B2 (en) | 2009-01-12 | 2013-06-25 | Biokier, Inc. | Composition and method for treatment of diabetes |
BR112012006437A2 (pt) | 2009-09-23 | 2016-04-19 | Biokier Inc | composições e métodos para tratamento do diabetes e outros distúrbios |
CN103702668A (zh) | 2011-05-02 | 2014-04-02 | 拜奥基尔公司 | 治疗糖尿病的组合物和方法 |
US20150073057A1 (en) | 2013-09-06 | 2015-03-12 | Biokier, Inc. | Composition and method for treatment of diabetes |
CN111302971B (zh) | 2018-12-12 | 2023-08-22 | 上海奥博生物医药股份有限公司 | 一种连续制备5-氰二醇的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
GB8419963D0 (en) * | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
DE69801764T2 (de) * | 1997-07-08 | 2002-07-04 | H. Lundbeck A/S, Kobenhavn-Valby | Verfahren zur herstellung von citalopram |
UA62985C2 (en) * | 1997-11-10 | 2004-01-15 | Lunnbeck As H | A method for the preparation of citalopram |
CZ292911B6 (cs) * | 1997-11-11 | 2004-01-14 | H. Lundbeck A/S | Způsob výroby citalopramu |
CA2435925A1 (en) * | 2001-01-30 | 2002-08-08 | Orion Corporation Fermion | Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile |
US6967259B2 (en) * | 2001-09-24 | 2005-11-22 | Pharmachem Technologies Limited | Process for the preparation of Citalopram intermediate |
-
2003
- 2003-10-28 DK DK03425693T patent/DK1506963T3/da active
- 2003-10-28 DE DE60300502T patent/DE60300502T2/de not_active Expired - Fee Related
- 2003-10-28 ES ES03425693T patent/ES2240931T3/es not_active Expired - Lifetime
- 2003-10-28 PT PT03425693T patent/PT1506963E/pt unknown
- 2003-10-28 EP EP03425693A patent/EP1506963B1/de not_active Expired - Lifetime
- 2003-10-28 SI SI200330042T patent/SI1506963T1/xx unknown
- 2003-10-28 AT AT03425693T patent/ATE293106T1/de not_active IP Right Cessation
-
2004
- 2004-10-22 JP JP2006537287A patent/JP2007511477A/ja active Pending
- 2004-10-22 CN CNA200480031662XA patent/CN1875013A/zh active Pending
- 2004-10-22 US US10/577,869 patent/US20070060759A1/en not_active Abandoned
- 2004-10-22 EP EP04791287A patent/EP1682526B1/de active Active
- 2004-10-22 DE DE602004019127T patent/DE602004019127D1/de not_active Expired - Fee Related
- 2004-10-22 AT AT04791287T patent/ATE420870T1/de not_active IP Right Cessation
- 2004-10-22 WO PCT/EP2004/052626 patent/WO2005049595A1/en active Application Filing
- 2004-10-22 BR BRPI0415778-8A patent/BRPI0415778A/pt not_active IP Right Cessation
- 2004-10-22 DK DK04791287T patent/DK1682526T3/da active
- 2004-10-22 PL PL379659A patent/PL379659A1/pl not_active Application Discontinuation
- 2004-10-22 CA CA002543155A patent/CA2543155A1/en not_active Abandoned
-
2005
- 2005-08-16 HK HK05107094A patent/HK1075041A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60300502D1 (de) | 2005-05-19 |
WO2005049595A1 (en) | 2005-06-02 |
ES2240931T3 (es) | 2005-10-16 |
DK1682526T3 (da) | 2009-03-23 |
ATE293106T1 (de) | 2005-04-15 |
PL379659A1 (pl) | 2006-10-30 |
EP1682526B1 (de) | 2009-01-14 |
CA2543155A1 (en) | 2005-06-02 |
US20070060759A1 (en) | 2007-03-15 |
PT1506963E (pt) | 2005-08-31 |
JP2007511477A (ja) | 2007-05-10 |
HK1075041A1 (en) | 2005-12-02 |
DE602004019127D1 (de) | 2009-03-05 |
CN1875013A (zh) | 2006-12-06 |
SI1506963T1 (en) | 2005-10-31 |
EP1506963B1 (de) | 2005-04-13 |
DK1506963T3 (da) | 2005-08-01 |
EP1506963A1 (de) | 2005-02-16 |
EP1682526A1 (de) | 2006-07-26 |
BRPI0415778A (pt) | 2006-12-26 |
DE60300502T2 (de) | 2006-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1075041A1 (en) | Method for the preparation of citalopram | |
ATE478084T1 (de) | Verfahren zur herstellung von 4'- azidocytidinderivaten | |
EA200500037A1 (ru) | Фенилбензамиды | |
DE60014548D1 (de) | Verfahren zur Herstellung eines 5-Phthalancarbonitrils, Zwischenprodukt dafür und Verfahren zur Herstellung des Zwischenproduktes | |
EA200702551A1 (ru) | Способ получения эпоксида из хлоргидрина | |
CA2471952A1 (en) | Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists | |
DE60225708D1 (de) | Verfahren zur herstellung von kollagen-produktionsverstärkern und verwendung | |
EA200500723A1 (ru) | Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний | |
MX2007004698A (es) | Sintesis asimetrica de dihidrobenzofuranos sustituidos. | |
ATE331713T1 (de) | Verfahren zur herstellung von 5-nitrobenzofuranen | |
ATE455087T1 (de) | Verfahren zur herstellung von 2,5- dimethylphenylessigsäure | |
DE60209537D1 (de) | Neue kristalline formen von meloxicam, deren herstellung und verfahren zu deren umwandlung ineinander | |
DE59910677D1 (de) | Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen | |
ATE253568T1 (de) | Verfahren zur herstellung von citalopram | |
EA200200939A1 (ru) | Способ получения циталопрама | |
EA200201211A1 (ru) | Способ получения циталопрама | |
EA200600563A1 (ru) | Способ получения рензаприда и его промежуточных соединений | |
DE602004023102D1 (de) | Verfahren zur herstellung kristalliner formen von orlistat | |
DE69920834D1 (de) | Verfahren zur Herstellung von substituierte piperidinepoxiden | |
JP2002220391A5 (de) | ||
HUP0401197A2 (hu) | Eljárás 3-brómmetil-benzoesav-származékok előállítására | |
ATE380190T1 (de) | Verbessertes verfahren zur herstellung von 5,6 - dihydro -4h-4(s)-ethylamin-6(s)-methylthieno(2,3- b) thiopyran-2-sulfonamid- 7,7 -dioxid und seinen salzen | |
EA200801868A1 (ru) | Способ получения 3,4-дизамещенных фенилуксусных кислот и новых промежуточных соединений | |
ATE160564T1 (de) | Herstellung von 3-dihaloacetyl oxazolidine | |
DE60223274D1 (de) | Verfahren zur herstellung von 17beta-(substituierten)-3-oxo-delta 1,2-4-azasteroiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |